1. Zakaria S, Degnim AC. Prophylactic Mastectomy. Surg Clin N Am 87 (2007) 317-331 [DOI via Crossref] [Pubmed] | | 2. Unukovych D, Sandelin K, Liljegren A, Arver B, Wickman M, Johansson H, et al. Contralateral prophylactic mastectomy in breast cancer patients with a family history: A prospective 2-years follow-up study of health-related quality of life, sexuality and body image. European Journal of Cancer (2012) 48, 3150-3156 [DOI via Crossref] [Pubmed] | | 3. Boughey JC, Hoskin TL, Degnim AC, Sellers TA, Johnson JL, Kasner MJ, et al. Contralateral Prophylactic Mastectomy is Associated with a Survival Advantage in High-Risk Women with a Personal History of Breast Cancer. Ann Surg Oncol (2010) 17:2702-2709 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 4. Brewster AM and Parker PA. Current Knowledge on Contralateral Prophylactic Mastectomy Among Women with Sporadic Breast Cancer. The Oncologist 2011;16:935-941 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 5. Grimmer L, Liederbach E, Velasco J, Pesce C, Wang CH, Yao K. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base. J Am Coll Surg 2015;221:187e196 | | 6. Morrow M. Prophylactic mastectomy of the contralateral breast. The Breast 2011, S3, S108-S110 [DOI via Crossref] | | 7. Rueth NM, McMahon M, Arrington AK, Swenson K, Leach J, Tuttle TM. Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction. Ann Surg Oncol. 2011, 18(9): 2515-2520. [DOI via Crossref] [Pubmed] | | 8. Chagpar AB. Prophylactic Bilateral Mastectomy and Contralateral Prophylactic Mastectomy. Surg Oncol Clin N Am 2014, 23, (3) 423-30 [DOI via Crossref] [Pubmed] | | 9. Lizarraga IM, Sugg SL, Weigel RJ, Scott-Conner CEH. Review of risk factors for the development of contralateral breast cancer. The American Journal of Surgery, 2013, 206, (5) 704-708 [DOI via Crossref] [Pubmed] | | 10. Soran A, Polat AK, Johnson R, McGuire KP. Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon? The Surgeon (2014), 12, (6), 316-22 [DOI via Crossref] [Pubmed] | | 11. Khurana KK, Loosmann A, Numann PJ, Khan SA. Prophylactic mastectomy: pathologic findings in high-risk patients. Arch Pathol Lab Med. 2000, 124(3):378-381 [Pubmed] | | 12. Damle S, Teal CB, Lenert JJ, Marshall EC, Pan Q, McSwain AP. Mastectomy and Contralateral Prophylactic Mastectomy Rates: An Institutional Review. Indian J Surg Oncol (April-June 2011) 2(2):133-140 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 13. Rosenberg SM, Tracy MS, Meyer M, Sepucha K, Gelber S, Hirshfield-Bartek J, et al. Perceptions, knowledge, and satisfaction with contralateral prophylactic mastectomy among young women with breast cancer: A cross-sectional survey. Ann Intern Med. 2013 September 17; 159(6): 373-381. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 14. Tracy MS, Rosenberg SM, Dominici L, Partridge AH. Contralateral prophylactic mastectomy in women with breast cancer: Trends, predictors, and areas for future research. Breast Cancer Res Treat. 2013 August; 140(3) 447-52 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 15. Yakoub D, Avisar E, Koru-Sengul T, et al. Factors associated with contralateral preventive mastectomy. Breast Cancer: Targets and Therapy 2015:7 1-8 [DOI via Crossref] | | 16. Goin MK, Goin JM. Psychological reactions to prophylactic mastectomy synchronous with contralateral breast reconstruction. Plast Reconstr Surg. 1982, 70(3):355-359 [DOI via Crossref] [Pubmed] | | 17. Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, et al. The Association Between Contralateral Prophylactic Mastectomy and Breast Cancer Outcomes by Hormone Receptor Status. Cancer. 2012 November 15; 118(22): 5637-5643. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 18. Graves KD, Peshkin BN, Halbert CH, DeMarco TA, Isaacs C, Schwartz MD. Predictors and Outcomes of Contralateral Prophylactic Mastectomy Among Breast Cancer Survivors. Breast Cancer Res Treat. 2007 September; 104(3): 321-329 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 19. Beesley H, Holcombe C, Brown SL, Salmon P. Risk, worry and cosmesis in decision-making for contralateral risk-reducing mastectomy: Analysis of 60 consecutive cases in a specialist breast unit. The Breast 22 (2013) 179-184 [DOI via Crossref] [Pubmed] | | 20. Quan G, Pommier SJ, Pommier RF. Incidence and outcomes of contralateral breast cancers. The American Journal of Surgery (2008) 195, 645-650 [DOI via Crossref] [Pubmed] | | 21. Frost MH, Hoskin TL, Hartmann LC, Degnim AC, Johnson JL, Boughey JC. Contralateral Prophylactic Mastectomy: Long-Term Consistency of Satisfaction and Adverse Effects and the Significance of Informed Decision-Making, Quality of Life, and Personality Traits. Ann Surg Oncol. 2011 October; 18(11): 3110-3116. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 22. Sahin I, Isik S, Alhan D, Yildiz R, Aykan A, Ozturk E. One-staged silicone implant breast reconstruction following bilateral nipple-sparing prophylactic mastectomy. Aesthetic Plastic Surg. 2013, 37(2):303-311 [DOI via Crossref] [Pubmed] | | 23. Jarrett JR, Cutler RG, Teal DF. Aesthetic refinements in prophylactic subcutaneous mastectomy with submuscular reconstruction. Plast Reconstr Surg. 1982, 69(4): 624-631 [DOI via Crossref] [Pubmed] | | 24. Jarrett JR, Cutler RG, Teal DF. Subcutaneous mastectomy in small, large, or ptotic breasts with immediate submuscular placement of implants. Plast Reconstr Surg. 1978, 62(5):702-705 [DOI via Crossref] [Pubmed] | | 25. Rubin LR. Prophylactic mastectomy with immediate reconstruction for the high-risk woman. Clin Plast Surg. 1984, 11(2):369-381 [Pubmed] | | 26. Woods JE, Verheyden CN. Pitfalls and problems with subcutaneous mastectomy. Mayo Clin Proc. 1980, 55(11):687-693 [Pubmed] | | 27. Bayram Y, Kulahci Y, Irgil C, Calikapan M, Novan N. Skin-reducing subcutaneous mastectomy using a dermal barrier flap and immediate breast reconstruction with an implant: a new surgical design for reconstruction of early-stage breast cancer. Aesthetic Plast Surg. 2010, 34(1): 71-77 [DOI via Crossref] [Pubmed] | | 28. Maillard GF, Garey LJ. An improved technique for immediate retropectoral reconstruction after subcutaneous mastectomy. Plast Reconstr Surg. 1987, 80(3):396-408 [DOI via Crossref] [Pubmed] | | 29. Murphy JA, Milner TD, O’Donoghue JM. Contralateral risk-reducing mastectomy in sporadic breast Cancer. www.thelancet.com/oncology Vol 14 June 2013 | | 30. Barton MB, West CN, Liu IL, Liu IL, Harris EL, Rolnick SG. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005;(35):61-66 [DOI via Crossref] [Pubmed] | | 31. Hamdi M, Blondeel P, Van Landuit K, Tondu T, Monstrey S. Bilateral autogenous breast reconstruction using perforator free flaps: a single center's experience. Plast Reconstr Surg. 2004, 114(1):83-89 [DOI via Crossref] [Pubmed] | | 32. Bedrosian I, Hu CY, Chang GJ. Population-Based Study of Contralateral Prophylactic Mastectomy and Survival Outcomes of Breast Cancer Patients. J Natl Cancer Inst 2010;102:401-409 [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 33. Isern AE, Loman N, Malina J, Olsson H, Ringberg A. Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer. EJSO 2008, 34 1148 - 1154 [DOI via Crossref] [Pubmed] | | 34. Zendejas B, Moriarty JP, O’Byrne J, Degnim AC, Farley DR, Boughey JC. Cost-Effectiveness of Contralateral Prophylactic Mastectomy Versus Routine Surveillance in Patients With Unilateral Breast Cancer. J Clin Oncol 2011, 29 (22) 2993-3000. [DOI via Crossref] [Pubmed] [PMC Free Fulltext] | | 35. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary E. Prophylactic Mastectomy. J Am Coll Surg, Vol. 191, No. 3, September 2000, 322-330 [DOI via Crossref] | |
|
|